Jasper Therapeutics, Inc.

JSPR

Jasper Therapeutics, Inc.

JSPR

Insider Sentiment (TTM):

Last Purchase:2025-09-22Last Sale:2024-12-12Shares Purchased (TTM):143,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:15,794,066Shares Outstanding:28,671,819Institutional Ownership Pct.:55.09%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Assets
Cash And Cash Equivalents At Carrying Value	7	14	29	51	40	49	72	93	107	118	87	104
Prepaid Expense And Other Assets Current	4	6	6	4	3	4	4	2	2	2	2	1
Assets Current	12	20	35	55	43	53	76	95	109	120	89	105
Property Plant And Equipment Net	0	0	0	1	1	2	2	2	2	2	3	3
Operating Lease Right Of Use Asset	0	0	1	1	2	2	1	1	1	1	1	2
Restricted Cash Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	1	1	1	1	1	1	0
Assets	12	21	36	57	46	58	80	99	114	126	95	110
Liabilities Current
Liabilities And Stockhold…
Accounts Payable Current	3	2	6	9	8	3	4	3	3	2	4	3
Operating Lease Liability Current	0	1	1	2	2	2	1	1	1	1	1	1
Accounts Payable And Other Accrued Liabilities Cur…	5	6	6	10	11	8	10	8	6	6	7	8
Liabilities Current	8	9	13	21	21	12	15	12	10	9	12	12
Operating Lease Liability Noncurrent	-	-	-	-	0	1	1	1	1	2	2	2
Warrants And Rights Outstanding	3	7	16	23	-	-	-	-	-	-	-	-
Other Liabilities Noncurrent	-	2	2	2	2	2	2	2	2	2	2	2
Liabilities	10	18	32	46	23	15	18	16	14	13	16	16
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	322	321	321	319	312	304	303	300	298	297	248	247
Retained Earnings Accumulated Deficit	-321	-318	-317	-308	-289	-262	-241	-217	-198	-183	-170	-153
Stockholders Equity	1	3	4	12	24	42	62	84	100	113	78	94
Liabilities And Stockholders Equity	12	21	36	57	46	58	80	99	114	126	95	110
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	492	492	492	492	492	492	492	492	492	492	492	492
Common Stock Shares Issued	28	28	28	28	16	15	15	15	15	15	11	11
Shares Outstanding	28	28	28	28	16	15	15	15	15	15	11	11

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-48.59%	-55.37%	-34.31%	-	-	-	-	-	-	-	-	-
2025	26.79%	42.83%	-39.24%	-8.42%	-16.16%	-23.23%	-3.93%	3.37%	-16.85%	-6.89%	0.33%	-49.67%
2024	17.21%	1.05%	-19.60%	-1.17%	-14.69%	12.84%	0.53%	-1.94%	-74.88%	-12.14%	-33.05%	-16.86%
2023	-	-	-	-	-	-	-15.20%	7.06%	58.75%	18.10%	-17.94%	-3.78%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.47	2.26	2.62	2.59	2.10	4.31	4.98	7.61	10.79	13.49	7.19	8.84
Quick Ratio	0.99	1.57	2.17	2.42	1.93	3.96	4.70	7.42	10.61	13.29	7.02	8.72
Working Capital	3.73M	11.30M	21.45M	33.52M	22.47M	40.84M	60.57M	82.35M	98.61M	111.39M	76.56M	93.31M
Leverage & Debt
Debt to Equity	7.35	5.23	7.62	3.97	0.98	0.36	0.30	0.19	0.14	0.11	0.21	0.17
Interest Coverage TTM	-	-	-	-	-	-	-	-582.03	-403.27	-251.75	-197.88	-234.23
Debt Ratio	0.88	0.84	0.88	0.80	0.49	0.27	0.23	0.16	0.12	0.10	0.17	0.15
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.11	-1.94	-3.95	-5.47	-5.93	-5.24	-4.89	-4.24	-4.17	-4.79	-6.18	-5.57
Free Cash Flow Per Share TTM	-2.39	-2.40	-4.03	-3.22	-3.30	-4.64	-4.29	-3.86	-3.73	-4.31	-4.99	-4.40
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-65.06%	-29.26%	6.36%	43.27%	45.62%	23.23%	10.55%	3.98%	12.67%	28.54%	71.06%	25.24%
EPS Growth (1Y)	-81.33%	-62.93%	-19.07%	29.19%	42.32%	9.39%	-20.87%	-23.94%	-17.89%	-15.29%	-40.22%	-58.26%
Valuation Metrics
P/E TTM	-0.38	-0.45	-0.46	-0.43	-0.94	-0.82	-4.38	-4.44	-5.45	-6.12	-1.28	-1.26
P/B TTM	8.55	7.39	8.45	3.42	3.62	1.53	5.06	3.37	3.39	3.46	1.05	0.82
Market Cap	12.08M	25.12M	35.08M	39.59M	85.10M	64.60M	311.82M	282.16M	340.19M	391.51M	82.36M	76.80M
Enterprise Value	4.35M	10.56M	5.97M	-11.72M	45.18M	15.38M	239.77M	189.24M	232.95M	272.62M	-4.94M	-27.48M
Calculated Values
Free Cash Flow TTM	-68.63M	-68.87M	-77.16M	-53.59M	-50.64M	-69.71M	-62.60M	-57.95M	-55.88M	-57.47M	-52.07M	-48.23M
Net Debt	-7.73M	-14.56M	-29.11M	-51.32M	-39.93M	-49.22M	-72.05M	-92.92M	-107.24M	-118.89M	-87.30M	-104.28M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-09-22Purchase

Owner: Wiggans, Thomas G

Title: -

Shares: 41,000

Price/Share: $2.43

Value: $99,630.00

Shares Owned: 41,000

Relationship: Director

Ownership: Indirect

2025-09-22Purchase

Owner: Shizuru, Judith Anne

Title: -

Shares: 41,000

Price/Share: $2.43

Value: $99,630.00

Shares Owned: 156,901

Relationship: Director

Ownership: Direct

2025-09-22Purchase

Owner: Martell, Ron

Title: President and CEO

Shares: 41,000

Price/Share: $2.43

Value: $99,630.00

Shares Owned: 74,118

Relationship: Director,Officer

Ownership: Direct

2025-09-22Purchase

Owner: Lucas, Svetlana

Title: -

Shares: 20,000

Price/Share: $2.43

Value: $48,600.00

Shares Owned: 20,000

Relationship: Director

Ownership: Direct

2024-12-12Sale

Owner: Mahal, Jeetinder Singh

Title: Chief Operating Officer

Shares: 900

Price/Share: $22.11

Value: $19,899.00

Shares Owned: 25,009

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-09-22	Wiggans, Thomas G	Director	-	Indirect	Purchase	41,000	2.43	$99,630.00	41,000	4
2025-09-22	Shizuru, Judith Anne	Director	-	Direct	Purchase	41,000	2.43	$99,630.00	156,901	4
2025-09-22	Martell, Ron	Director,Officer	President and CEO	Direct	Purchase	41,000	2.43	$99,630.00	74,118	4
2025-09-22	Lucas, Svetlana	Director	-	Direct	Purchase	20,000	2.43	$48,600.00	20,000	4
2024-12-12	Mahal, Jeetinder Singh	Officer	Chief Operating Officer	Direct	Sale	900	22.11	$19,899.00	25,009	4
2024-09-12	Mahal, Jeetinder Singh	Officer	Chief Operating Officer	Direct	Sale	900	21.23	$19,107.00	25,009	4
2024-06-12	Mahal, Jeetinder Singh	Officer	Chief Operating Officer	Direct	Sale	900	24.16	$21,744.00	25,009	4
2024-03-12	Mahal, Jeetinder Singh	Officer	Chief Operating Officer	Direct	Sale	900	26.44	$23,796.00	25,009	4
2024-02-08	Venkataraman, Balaji, Ave…	Other	-	Indirect	Purchase	350,000	12.95	$4,532,500.00	1,188,500	4
2024-02-08	Abingworth, Llp, Cg Subsi…	TenPercentOwner	-	Indirect	Purchase	190,000	12.95	$2,460,500.00	1,066,189	4
2023-11-28	Wiggans, Thomas G	Director	-	Direct	Purchase	10,000	0.65	$6,500.00	50,000	4
2023-11-21	Wiggans, Thomas G	Director	-	Direct	Purchase	10,000	0.64	$6,400.00	40,000	4
2023-11-20	Wiggans, Thomas G	Director	-	Direct	Purchase	10,000	0.63	$6,300.00	30,000	4
2023-10-13	Lis, William	Director	-	Direct	Sale	7,965	0.85	$6,770.25	53,521	4
2023-06-13	Mahal, Jeetinder Singh	Officer	See Remarks	Direct	Sale	9,000	1.66	$14,940.00	287,223	4
2023-04-14	French, Anna Louise	Director	-	Direct	Sale	7,000	1.48	$10,360.00	23,750	4
2023-04-13	Emster, Kurt Von	Director	-	Direct	Sale	9,075	1.49	$13,521.75	21,175	4
2023-04-13	Lis, William	Director	-	Direct	Sale	8,500	1.44	$12,240.00	61,486	4
2023-01-27	Qiming, U.S. Healthcare G…	TenPercentOwner	-	Direct	Purchase	2,666,666	1.50	$3,999,999.00	8,519,648	4
2023-01-27	Tc, Group, Llc, Carlyle H…	TenPercentOwner	-	Indirect	Purchase	3,133,333	1.50	$4,699,999.50	8,761,891	4
2023-01-25	Roche, Finance Ltd, Roche…	TenPercentOwner	-	Indirect	Sale	75,000	1.89	$141,750.00	4,549,606	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

55.09%

Inst. Shares: 15,794,066

Shares Outstanding: 28,671,819

2025-12-31

94.85%

Inst. Shares: 18,181,476

Shares Outstanding: 19,168,110

2025-09-30

114.98%

Inst. Shares: 19,127,709

Shares Outstanding: 16,635,784

2025-06-30

76.82%

Inst. Shares: 11,780,168

Shares Outstanding: 15,333,962

2025-03-31

81.74%

Inst. Shares: 12,279,472

Shares Outstanding: 15,022,122

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	15,794,066	28,671,819	55.09%
2025-12-31	18,181,476	19,168,110	94.85%
2025-09-30	19,127,709	16,635,784	114.98%
2025-06-30	11,780,168	15,333,962	76.82%
2025-03-31	12,279,472	15,022,122	81.74%
2024-12-31	15,540,548	14,584,870	106.55%
2024-09-30	14,653,555	15,000,516	97.69%
2024-06-30	14,542,377	14,986,367	97.04%
2024-03-31	12,932,562	13,334,900	96.98%
2023-12-31	72,242,689	10,439,034	-
2023-09-30	90,770,864	10,971,945	-
2023-06-30	87,523,976	10,921,239	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Jasper Therapeutics, Inc. (JSPR) — SEC Financial Statements & Analysis

Jasper Therapeutics, Inc. (JSPR) is a biological products, (no diagnostic substances) company, incorporated in DE. Jasper Therapeutics, Inc. trades on Nasdaq as: JSPR, JSPRW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Jasper Therapeutics, Inc. reported a Debt-to-Equity ratio of 7.35x, a Price-to-Book (P/B) ratio of 8.55x (TTM), at a market cap of $12.08M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 7.35x
P/B TTM: 8.55x
Market Cap: $12.08M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Jasper Therapeutics, Inc. in?

Jasper Therapeutics, Inc. (JSPR) operates in the Biological Products, (No Diagnostic Substances) industry.

What is JSPR's market cap?

Jasper Therapeutics, Inc. (JSPR) has a market capitalization of $12.08M as of 2026-06-30.

What exchange does JSPR trade on?

Jasper Therapeutics, Inc. (JSPR) trades on the Nasdaq.

Where is Jasper Therapeutics, Inc. incorporated?

Jasper Therapeutics, Inc. is incorporated in DE.